SCHEMBL6002465

SCHEMBL6002465

CCCCCCOc1ccc(-c2ncc[nH]2)cc1

nearest known ligand 0.91

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP2D6 P10635 8/20 0.91
CYP1A2 P05177 6/20 0.91
CYP19A1 P11511 6/20 0.91
CYP2C9 P11712 6/20 0.91
CYP2C19 P33261 6/20 0.91
CYP3A4 P08684 5/20 0.91
KCNH2 Q12809 1/20 0.58
HRH3 Q9Y5N1 1/20 0.58
NISCH Q9Y2I1 1/20 0.51
HPGD P15428 3/20 0.51
LMNA P02545 1/20 0.51
POLB P06746 1/20 0.51
RAB9A P51151 1/20 0.51
SMN1; SMN2 Q16637 1/20 0.51
NR5A1 Q13285 1/20 0.50
RARB P10826 3/20 0.49
KDM4E B2RXH2 3/20 0.47
ALDH1A1 P00352 3/20 0.47
HTT P42858 1/20 0.47
L3MBTL1 Q9Y468 1/20 0.47

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4723390 0.95 CYP2D6 (1.00) CYP2D6CYP1A2CYP19A1CYP2C9CYP2C19
SCHEMBL4723343 0.89 CYP1A2 (0.88) CYP2D6CYP1A2CYP19A1CYP2C9CYP2C19
SCHEMBL3407136 0.82 CYP1A2 (0.76) CYP2D6CYP1A2CYP19A1CYP2C9CYP2C19
SCHEMBL6941842 0.81 CYP1A2 (0.73) CYP2D6CYP1A2CYP19A1CYP2C9CYP2C19
SCHEMBL12462292 0.80 CYP1A2 (0.72) CYP2D6CYP1A2CYP19A1CYP2C9CYP2C19
SCHEMBL6575763 0.80 CYP3A4 (0.71) CYP2D6CYP1A2CYP19A1CYP2C9CYP2C19
SCHEMBL14599590 0.79 CYP1A2 (0.70) CYP2D6CYP1A2CYP19A1CYP2C9CYP2C19
SCHEMBL11937116 0.78 CYP3A4 (0.56) CYP2D6CYP1A2CYP19A1CYP2C9CYP2C19
Methyl Alcohol SCHEMBL10336733 0.78 CYP1A2 (0.69) CYP2D6CYP1A2CYP19A1CYP2C9CYP2C19
SCHEMBL9153965 0.78 RARB (0.71) CYP2D6CYP1A2CYP19A1CYP2C9CYP2C19

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1678185-A1 2,3-DIHYDRO-6-NITROIMIDAZO [2,1-B] OXAZOLE COMPOUNDS FOR THE TREATMENT OF TUBERCULOSIS OTSUKA PHARMACEUTICAL CO., LTD. (JP) 2006-07-12 EP disclosed
WO-2005042542-A1 2,3-DIHYDRO-6-NITROIMIDAZO (2,1-B) OXAZOLE COMPOUNDS FOR THE TREATMENT OF TUBERCULOSIS OTSUKA PHARMACEUTICAL CO., LTD. (JP) 2005-05-12 WO disclosed
US-5811456-A TREATMENT OF ALZHEIMER'S DISEASE LABORATOIRES MAYOLY SPINDLER (FR) 1998-09-22 US disclosed